| 28.10.2008 | Amylin Pharmaceuticals Downgrade | Morgan Stanley |  |
| 23.10.2008 | Amylin Pharmaceuticals neutral | Cowen and Company, LLC |  |
| 23.10.2008 | Amylin Pharmaceuticals neues Kursziel | Barclays Capital |  |
| 23.10.2008 | Amylin Pharmaceuticals buy | Goldman Sachs Group Inc. |  |
| 07.10.2008 | Amylin Pharmaceuticals Upgrade | Citigroup Corp. |  |
| 06.10.2008 | AmylinPharmaceuticals outperform | Leerink Swann LLC |  |
| 26.09.2008 | Amylin Pharmaceuticals neutral | Robert W. Baird & Co. Incorporated |  |
| 03.09.2008 | Amylin Pharmaceuticals equal weight | Lehman Brothers Inc. |  |
| 29.08.2008 | Amylin Pharmaceuticals buy | Merrill Lynch & Co., Inc. |  |
| 28.08.2008 | Amylin Pharmaceuticals buy | Piper Jaffray & Co. |  |
| 28.08.2008 | Amylin Pharmaceuticals sell | Citigroup Corp. |  |
| 28.08.2008 | Amylin Pharmaceuticals neues Kursziel | Lehman Brothers Inc. |  |
| 27.08.2008 | Amylin Pharmaceuticals Downgrade | Robert W. Baird & Co. Incorporated |  |
| 27.08.2008 | Amylin Pharmaceuticals sell | Soleil Securities Group, Inc. |  |
| 25.08.2008 | Amylin Pharmaceuticals outperform | Leerink Swann LLC |  |
| 22.08.2008 | Amylin Pharmaceuticals buy | Goldman Sachs Group Inc. |  |
| 21.08.2008 | Amylin Pharmaceuticals sell | Citigroup Corp. |  |
| 20.08.2008 | Amylin Pharmaceuticals buy | Piper Jaffray & Co. |  |
| 20.08.2008 | Amylin Pharmaceuticals neues Kursziel | Morgan Stanley |  |
| 19.08.2008 | Amylin Pharmaceuticals Downgrade | Stanford Financial Group, Inc. |  |
| 24.06.2008 | Amylin Pharmaceuticals outperform | Robert W. Baird & Co. Incorporated |  |
| 10.06.2008 | Amylin Pharmaceuticals sell | Citigroup Corp. |  |
| 09.06.2008 | Amylin Pharmaceuticals Downgrade | Jefferies & Company Inc. |  |
| 28.05.2008 | Amylin Pharmaceuticals Upgrade | Lehman Brothers Inc. |  |
| 22.04.2008 | Amylin Pharmaceuticals neues Kursziel | Lehman Brothers Inc. |  |
| 22.04.2008 | Amylin Pharmaceuticals spekulativ | Global Biotech Investing |  |
| 22.04.2008 | Amylin Pharmaceuticals neues Kursziel | Friedman, Billings, Ramsey Group, Inc. |  |
| 30.01.2008 | Amylin Pharmaceuticals buy | Stanford Financial Group |  |
| 30.01.2008 | Amylin Pharmaceuticals neues Kursziel | Friedman, Billings Ramsey & Co |  |
| 16.01.2008 | Amylin Pharmaceuticals outperform | Robert W. Baird & Co. Incorporated |  |
| 07.01.2008 | Amylin Pharmaceuticals neues Kursziel | Friedman, Billings Ramsey & Co |  |
| 13.12.2007 | Amylin Pharmaceuticals underweight | Lehman Brothers Inc. |  |
| 30.11.2007 | Amylin Pharmaceuticals underweight | Lehman Brothers Inc. |  |
| 29.11.2007 | Amylin Pharmaceuticals neues Kursziel | Friedman, Billings Ramsey & Co |  |
| 28.11.2007 | Amylin Pharmaceuticals outperform | Bear Stearns Companies Inc. |  |
| 20.11.2007 | Amylin Pharmaceuticals outperform | Piper Jaffray & Co. |  |
| 12.11.2007 | Amylin Pharmaceuticals Ersteinschätzung | JP Morgan Chase & Co. |  |
| 01.11.2007 | Amylin Pharmaceuticals Downgrade | Lehman Brothers Inc. |  |
| 01.11.2007 | Amylin Pharmaceuticals Downgrade | Rodman & Renshaw |  |
| 19.10.2007 | Amylin Pharmaceuticals neues Kursziel | Goldman Sachs Group Inc. |  |
Seite: 1 | 2 | 3  |